What is the strongest evidence for GHK-Cu?

The most cited evidence is in-vitro (cell culture) and gene-expression work, plus review articles largely authored by its discoverer. Rigorous randomized human efficacy trials are lacking.

How does GHK-Cu relate to collagen?

In laboratory studies, GHK-Cu stimulates collagen and glycosaminoglycan synthesis and modulates matrix metalloproteinases, which is the basis for interest in skin remodeling.

Is injectable GHK-Cu safe?

Systemic and injectable human safety data are limited. Topical cosmetic use is generally considered well tolerated, but injectable use has not been formally evaluated for safety in controlled human studies.

Does GHK decline with age?

Reviews report that endogenous plasma GHK falls from roughly 200 ng/mL around age 20 to about 80 ng/mL by age 60, though this is descriptive rather than proof of a therapeutic effect.

Research chemical — not approvedaka Copper tripeptide-1, Copper peptide, Gly-His-Lys copper

GHK-Cu — Complete Research Guide (2026)

Last updated 2026-06-25

TL;DR

A copper-binding tripeptide present naturally in human plasma. Widely used in topical cosmetic formulations; studied for skin and wound-related effects.

What is GHK-Cu?

GHK-Cu is the copper(II) complex of the naturally occurring human tripeptide glycyl-L-histidyl-L-lysine (GHK), first isolated from human plasma by Pickart in 1973; endogenous GHK levels decline with age.

It is used as a cosmetic and research ingredient, not an approved medicine - there is no FDA or EMA drug approval for GHK-Cu, and the human evidence base is dominated by in-vitro work and author reviews rather than controlled clinical trials.

Most published mechanistic data come from cell-culture and gene-expression studies; robust randomized human efficacy trials for skin or systemic outcomes are lacking.

How does GHK-Cu work?

GHK binds copper with high affinity and, at nanomolar concentrations, stimulates synthesis of collagen and glycosaminoglycans while modulating matrix metalloproteinases and their inhibitors.

Gene-expression analyses report that GHK can up- or down-regulate thousands of human genes linked to extracellular-matrix remodeling, antioxidant defense, and anti-inflammatory signaling. [INFOGRAPHIC: GHK-Cu copper binding and collagen synthesis pathway]

What does the research say about GHK-Cu?

In laboratory and review evidence, GHK-Cu stimulates collagen and glycosaminoglycan synthesis and modulates the metalloproteinases involved in skin matrix remodeling. ^[1]
In vitro, GHK-Cu accelerated the growth of irradiated human fibroblasts and increased their output of bFGF and VEGF toward normal levels. ^[4]
Gene-data reviews report GHK can regulate large numbers of human genes tied to tissue repair, antioxidant and anti-inflammatory pathways. ^[2]

Clinical research & studies

The references below are the primary sources cited throughout this guide. Each links directly to PubMed or the regulator. Where evidence is preclinical (animal or in-vitro), that is stated rather than implied.

[1] GHK Peptide as a Natural Modulator of Multiple Cellular Pathways in Skin Regeneration — Pickart L, Margolina A, Biomed Res Int 2015. (review)
[2] Regenerative and Protective Actions of the GHK-Cu Peptide in the Light of the New Gene Data — Pickart L, Margolina A, Int J Mol Sci 2018. (review)
[3] The human tripeptide GHK-Cu in prevention of oxidative stress and degenerative conditions of aging: implications for cognitive health — Pickart L, Vasquez-Soltero JM, Margolina A, Oxid Med Cell Longev 2012. (review)
[4] Effects of copper tripeptide on the growth and expression of growth factors by normal and irradiated fibroblasts — Pollard JD, Quan S, Kang T, Koch RJ, Arch Facial Plast Surg 2005. (in-vitro (human fibroblasts))
[5] The effect of copper tripeptide and tretinoin on growth factor production in a serum-free fibroblast model — McCormack MC, Nowak KC, Koch RJ, Arch Facial Plast Surg 2001. (in-vitro (human fibroblasts))

Dosing context

This is not medical advice or a usage recommendation. Dosing figures are reported research context only, cited from the published literature.

In the literature, effects are reported at nanomolar concentrations in cell culture and at topical formulation levels in cosmetic research; these are experimental conditions, not human dosing guidance.

No validated human systemic dose has been established in controlled trials, so no usage recommendation can be responsibly derived from this evidence.

Side effects & safety profile

Topical GHK-Cu is widely used in cosmetics and is generally regarded as well tolerated on skin, but systemic and injectable human safety data are limited and it has not undergone formal regulatory safety review as a drug.

No reliable human pharmacokinetic parameters (including half-life) are established in the peer-reviewed literature reviewed here, so any specific half-life figure would be speculative.

Because most data are preclinical, long-term systemic safety in humans is essentially uncharacterized.

Stacking & combinations

One in-vitro study paired GHK-Cu with tretinoin, but there are no controlled human studies of GHK-Cu combined with other actives, so combination effects remain unproven.

Finding GHK-Cu vendors

This is an independent, neutral directory — we sell nothing and route no purchases. Use it to read regulatory context and (where available) genuine, moderated vendor information for your country.

Choose your country

We never list placeholder vendors. Pick your country to see neutral regulatory context.

Browse the directory

User reviews

No reviews yet

Reviews appear here once submitted and moderated. An aggregate rating is shown only after at least 5 genuine reviews — we never fabricate ratings.

Frequently asked questions

No. It is a naturally occurring human peptide used as a cosmetic and research ingredient. It has no FDA or EMA drug approval for any therapeutic indication.

References

[1] GHK Peptide as a Natural Modulator of Multiple Cellular Pathways in Skin Regeneration — Pickart L, Margolina A, Biomed Res Int 2015. PMID: 26236730. View sourceStudy: reviewReviews evidence that GHK-Cu stimulates collagen/glycosaminoglycan synthesis and modulates metalloproteinases during skin repair.
[2] Regenerative and Protective Actions of the GHK-Cu Peptide in the Light of the New Gene Data — Pickart L, Margolina A, Int J Mol Sci 2018. PMID: 29986520. View sourceStudy: reviewSummarizes gene-expression data indicating GHK modulates thousands of genes involved in repair, antioxidant and anti-inflammatory pathways.
[3] The human tripeptide GHK-Cu in prevention of oxidative stress and degenerative conditions of aging: implications for cognitive health — Pickart L, Vasquez-Soltero JM, Margolina A, Oxid Med Cell Longev 2012. PMID: 22666519. View sourceStudy: reviewArgues GHK-Cu has antioxidant and anti-inflammatory actions relevant to age-related degeneration, based largely on preclinical data.
[4] Effects of copper tripeptide on the growth and expression of growth factors by normal and irradiated fibroblasts — Pollard JD, Quan S, Kang T, Koch RJ, Arch Facial Plast Surg 2005. PMID: 15655171. View sourceStudy: in-vitro (human fibroblasts)GHK-Cu restored proliferation and increased bFGF/VEGF in irradiated fibroblasts toward normal-control levels.
[5] The effect of copper tripeptide and tretinoin on growth factor production in a serum-free fibroblast model — McCormack MC, Nowak KC, Koch RJ, Arch Facial Plast Surg 2001. PMID: 11176716. View sourceStudy: in-vitro (human fibroblasts)Copper tripeptide reduced TGF-beta1 production in normal and keloid fibroblasts in a serum-free model.

Related peptides

BPC-157Healing & Recovery TB-500Healing & Recovery KPVHealing & Recovery

This article is for educational and research purposes only. Peptides discussed here are not approved for human consumption by the FDA, EMA, or equivalent regulators outside of specific clinical contexts. Always consult a licensed medical professional before any therapeutic use.